Thanks.
Footnote 3 is just the brand name.
I still don't see why "time to onset" matters.
What matters is the release rate over the period between doses.
I'd be more comfortable if the P2 was repeated with the weekly formulation before starting a P3. But that isn't the plan.
- Forums
- ASX - By Stock
- IXC
- Ann: Notice of Investor Call and Presentation
Ann: Notice of Investor Call and Presentation, page-50
-
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 532 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 8695 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 532 | 0.073 |
1 | 12158 | 0.071 |
1 | 62163 | 0.070 |
1 | 100000 | 0.063 |
1 | 100000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 8695 | 1 |
0.076 | 40000 | 1 |
0.080 | 19000 | 2 |
0.083 | 4000 | 1 |
0.090 | 126146 | 1 |
Last trade - 16.12pm 09/08/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable